UPPER RESP TRACT INFECTION
Clinical trials for UPPER RESP TRACT INFECTION explained in plain language.
Never miss a new study
Get alerted when new UPPER RESP TRACT INFECTION trials appear
Sign up with your email to follow new studies for UPPER RESP TRACT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cold virus drug shield COPD lungs?
Disease control CompletedThis study tested an experimental drug called vapendavir in 52 adults with COPD (a chronic lung disease). The goal was to see if the drug could reduce severe cold symptoms caused by rhinovirus, a common cold virus. Participants were given either vapendavir or a placebo and monito…
Matched conditions: UPPER RESP TRACT INFECTION
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
Which cough syrup works best? new study puts top remedies to the test
Symptom relief CompletedThis study tested three popular cough medicines—levodropropizine, codeine (with other ingredients), and ivy leaf extract—against a placebo in 196 adults with a cold and moderate to severe cough. Participants took the medicine three times a day for four days. The main goal was to …
Matched conditions: UPPER RESP TRACT INFECTION
Phase: PHASE4 • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC